These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7831449

  • 1. The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate.
    Gwirtsman HE, Szuba MP, Toren L, Feist M.
    Psychopharmacol Bull; 1994; 30(2):157-64. PubMed ID: 7831449
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT.
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [Abstract] [Full Text] [Related]

  • 3. [Combined tricyclic antidepressants and ritalin in elderly depressives].
    Naor S, Talmon Y, Guy N.
    Harefuah; 1992 Oct; 123(7-8):251-2, 307. PubMed ID: 1459498
    [Abstract] [Full Text] [Related]

  • 4. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 5. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N, Siobud-Dorocant E, Even C, Slama F, Dardennes R.
    Encephale; 2001 Apr; 27(4):373-6. PubMed ID: 11686060
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P.
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [Abstract] [Full Text] [Related]

  • 7. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
    Birkenhäger TK, Vegt M, Nolen WA.
    Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
    [Abstract] [Full Text] [Related]

  • 8. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP, Herbstein J, Damlouji N.
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [Abstract] [Full Text] [Related]

  • 9. d-Amphetamine versus methylphenidate effects in depressed inpatients.
    Little KY.
    J Clin Psychiatry; 1993 Sep; 54(9):349-55. PubMed ID: 8407854
    [Abstract] [Full Text] [Related]

  • 10. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD, Holman SL, Sayler ME, Potvin JH.
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ, Dragicevic A, Fric M, Gaertner I, Grasmäder K, Härtter S, Hermann E, Kuss HJ, Laux G, Oehl W, Rao ML, Rollmann N, Weigmann H, Weber-Labonte M, Hiemke C.
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and side effects of methylphenidate for poststroke depression.
    Lazarus LW, Winemiller DR, Lingam VR, Neyman I, Hartman C, Abassian M, Kartan U, Groves L, Fawcett J.
    J Clin Psychiatry; 1992 Dec; 53(12):447-9. PubMed ID: 1487474
    [Abstract] [Full Text] [Related]

  • 14. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
    Chan CH, Janicak PG, Davis JM, Altman E, Andriukaitis S, Hedeker D.
    J Clin Psychiatry; 1987 May; 48(5):197-200. PubMed ID: 3571174
    [Abstract] [Full Text] [Related]

  • 15. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L.
    J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772
    [Abstract] [Full Text] [Related]

  • 16. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 17. Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants.
    Gardner EA.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):157-62. PubMed ID: 6406449
    [Abstract] [Full Text] [Related]

  • 18. Acute response to methylphenidate as a predictor of outcome of treatment with TCAs in the elderly.
    Spar JA, La Rue A.
    J Clin Psychiatry; 1985 Nov; 46(11):466-9. PubMed ID: 4055706
    [Abstract] [Full Text] [Related]

  • 19. [Antidepressants consumption in the global population in France].
    Olié JP, Elomari F, Spadone C, Lépine JP.
    Encephale; 2002 Nov; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [Abstract] [Full Text] [Related]

  • 20. Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy.
    Amsterdam JD, Berwish N.
    J Clin Psychopharmacol; 1987 Aug; 7(4):238-42. PubMed ID: 3305592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.